Europe

The Great Pharma Brexit? An Endpoints News snap poll finds most life sciences insiders predicting a debacle for the industry
The Great Pharma Brexit? An Endpoints News snap poll finds most life sciences insiders predicting a debacle for the industry
Endpoints
pharma industry
UK
Europe
Brexit
Flag link:
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
CP Wire
Clovis Oncology
Europe
Rubraca
Flag link:
How Pharmaceuticals Impact the Environment: EMA Revises Guideline
How Pharmaceuticals Impact the Environment: EMA Revises Guideline
RAPS.org
Europe
EMA
environmental concerns
Flag link:
Novartis’ Gilenya gets approval in Europe to treat children and adolescents with MS
Novartis’ Gilenya gets approval in Europe to treat children and adolescents with MS
Pharmaceutical Business Review
Novartis
Gilenya
Europe
Relapsing Remitting Multiple Sclerosis
Flag link:
FDA to Follow EMA With Move From London to Amsterdam
FDA to Follow EMA With Move From London to Amsterdam
RAPS.org
FDA
Amsterdam
EMA
Europe
Flag link:
European Commission Approves Kalydeco to Treat Cystic Fibrosis
European Commission Approves Kalydeco to Treat Cystic Fibrosis
CP Wire
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Europe
Flag link:
Luxturna cleared for sale in Europe, but payer support uncertain
Luxturna cleared for sale in Europe, but payer support uncertain
Biopharma Dive
Spark Therapeutics
Luxturna
Europe
gene therapy
Flag link:
Pharma hopes for best, fears the worst, as Brexit vote nears
Pharma hopes for best, fears the worst, as Brexit vote nears
Pharmaforum
Brexit
UK
Europe
pharma industry
Flag link:
Novartis/Spark’s sight gene therapy approved in EU
Novartis/Spark’s sight gene therapy approved in EU
Pharmaforum
Novartis
Spark Therapeutics
Luxturna
gene therapy
Europe
Flag link:
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Endpoints
Takeda
shareholders
Japan
M&A
Shire
Europe
Flag link:
Novartis focusing on cutting CAR-T costs ahead of EU launches
Novartis focusing on cutting CAR-T costs ahead of EU launches
Pharmaforum
Novartis
CAR-T
Europe
Flag link:
What a draft Brexit agreement means for the medical device industry
What a draft Brexit agreement means for the medical device industry
Emergo
devices
UK
Europe
Brexit
Flag link:
Edwards Lifesciences wins CE Mark for Sapien 3 Ultra TAVR
Edwards Lifesciences wins CE Mark for Sapien 3 Ultra TAVR
Mass Device
Edwards Lifesciences
CE Mark
Europe
Sapien 3
TAVR
devices
Flag link:
Biopharma may have to wait for Brexit details
Biopharma may have to wait for Brexit details
BioCentury
Brexit
Europe
UK
Flag link:
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Channel News Asia
Takeda
Shire
M&A
Europe
Flag link:
#WeWontRest: The benefits of giving pharma a face
#WeWontRest: The benefits of giving pharma a face
Pharmaforum
Europe
pharma industry
social media
Flag link:
Half of Clinical Trials Fail to Publish Results, UK Report Finds
Half of Clinical Trials Fail to Publish Results, UK Report Finds
RAPS.org
clinical trials
UK
Europe
transparency
Flag link:
Reimbursement lags cancer drug approvals, but some European countries wait longer
Reimbursement lags cancer drug approvals, but some European countries wait longer
Biopharma Dive
Europe
drug approvals
reimbursement
Flag link:
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Flag link:
ESMO18: Novartis PI3K combo therapy boosts survival in subset of breast cancer patients
ESMO18: Novartis PI3K combo therapy boosts survival in subset of breast cancer patients
Fierce Biotech
Europe
Novartis
ESMO
AstraZeneca
breast cancer
BYL719
Flag link:

Pages